Bitolterol

	WikiDoc Resources for Bitolterol
Articles
Most recent articles on Bitolterol Most cited articles on Bitolterol Review articles on Bitolterol Articles on Bitolterol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Bitolterol Images of Bitolterol Photos of Bitolterol Podcasts & MP3s on Bitolterol Videos on Bitolterol
Evidence Based Medicine
Cochrane Collaboration on Bitolterol Bandolier on Bitolterol TRIP on Bitolterol
Clinical Trials
Ongoing Trials on Bitolterol at Clinical Trials.gov Trial results on Bitolterol Clinical Trials on Bitolterol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Bitolterol NICE Guidance on Bitolterol NHS PRODIGY Guidance FDA on Bitolterol CDC on Bitolterol
Books
Books on Bitolterol
News
Bitolterol in the news Be alerted to news on Bitolterol News trends on Bitolterol
Commentary
Blogs on Bitolterol
Definitions
Definitions of Bitolterol
Patient Resources / Community
Patient resources on Bitolterol Discussion groups on Bitolterol Patient Handouts on Bitolterol Directions to Hospitals Treating Bitolterol Risk calculators and risk factors for Bitolterol
Healthcare Provider Resources
Symptoms of Bitolterol Causes & Risk Factors for Bitolterol Diagnostic studies for Bitolterol Treatment of Bitolterol
Continuing Medical Education (CME)
CME Programs on Bitolterol
International
Bitolterol en Espanol Bitolterol en Francais
Business
Bitolterol in the Marketplace Patents on Bitolterol
Experimental / Informatics
List of terms related to Bitolterol

Bitolterol.png
Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
MedlinePlus	a601236
ATC code	R03AC17 (WHO) ;
Identifiers
	IUPAC name (RS)-[4-(1-Hydroxy-2-tert-butylamino-ethyl)-2-(4-methylbenzoyl)oxy-phenyl] 4-methylbenzoate;
CAS Number	30392-41-7;
PubChem CID	35330;
DrugBank	DB00901;
ChemSpider	32525;
UNII	9KY0QXD6LI;
ChEMBL	ChEMBL1201295 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C28H31NO5
Molar mass	461.549 g/mol
3D model (JSmol)	Interactive image;
	SMILES O=C(Oc2cc(ccc2OC(=O)c1ccc(cc1)C)C(O)CNC(C)(C)C)c3ccc(cc3)C;

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Bitolterol mesylate (Tornalate) is a β₂-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma^[1]^[2] and COPD.^[3]^[4]^[5] In these disorders there is a narrowing of the airways (bronchi and their ramifications) that carry air to the lungs. Muscle spasm and inflammation within the bronchi get worse this narrowing. Bitolterol relaxes the smooth muscles present continuously around the bronchi and bronchioles facilitating the flow of air through them.

Bitolterol has a rapid onset of action (2–5 minutes) and may last up to 6–8 hours.^[6] The drug, alone or in co-administration with theophylline, doesn't show cardiotoxic effect.^[7]

The USA Food and Drug Administration (FDA) approved bitolterol in December 1984. The drug was withdrawn from the market by Élan Pharmaceuticals in 2001.

References

↑ Nathan RA, Bodman SF, Storms WW, Mingo TS (June 1986). "Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol". Ann Allergy. 56 (6): 494–9. PMID 3717716.
↑ Nathan RA, Bernstein IL, Bronsky EA, Bush RK, Chervinsky P, Condemi JJ, Dockhorn RJ, Pinnas JL, Repsher LH (May 1987). "Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthma". J. Allergy Clin. Immunol. 79 (5): 822–9. doi:10.1016/0091-6749(87)90216-8. PMID 3571773.
↑ Friedel HA; Brogden RN (1988). "Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease". Drugs. 35: 22–41. doi:10.2165/00003495-198835010-00002.
↑ Anderson, JR.; Groves, PM.; Schwartz, GE. (Jan 1979). "Early Career Awards for 1978 (John Robert Anderson, Philip M. Groves, Gary E. Schwartz)". Am Psychol. 34 (1): 69–79. PMID 396832.
↑ Petty, TL.; Scoggin, CH.; Rollins, DR.; Repsher, LH. (Sep 1984). "Bitolterol compared to isoproterenol in advanced chronic obstructive pulmonary disease". Chest. 86 (3): 404–8. doi:10.1378/chest.86.3.404. PMID 6380974.
↑ Kass, I.; Mingo, TS. (Aug 1980). "Bitolterol mesylate (WIN 32784) aerosol. A new long-acting bronchodilator with reduced chronotropic effects". Chest. 78 (2): 283–7. doi:10.1378/chest.78.2.283. PMID 6995040.
↑ Kemp, JP.; Chervinsky, P.; Orgel, HA.; Meltzer, EO.; Noyes, JH.; Mingo, TS. (Jan 1984). "Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoring". J Allergy Clin Immunol. 73 (1 Pt 1): 32–43. doi:10.1016/0091-6749(84)90481-0. PMID 6693665.

Template:Asthma and copd rx

[pmid3717716-1] Nathan RA, Bodman SF, Storms WW, Mingo TS (June 1986). "Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol". Ann Allergy. 56 (6): 494–9. PMID 3717716.

[pmid3571773-2] Nathan RA, Bernstein IL, Bronsky EA, Bush RK, Chervinsky P, Condemi JJ, Dockhorn RJ, Pinnas JL, Repsher LH (May 1987). "Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthma". J. Allergy Clin. Immunol. 79 (5): 822–9. doi:10.1016/0091-6749(87)90216-8. PMID 3571773.

[3] Friedel HA; Brogden RN (1988). "Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease". Drugs. 35: 22–41. doi:10.2165/00003495-198835010-00002.

[Anderson-1979-4] Anderson, JR.; Groves, PM.; Schwartz, GE. (Jan 1979). "Early Career Awards for 1978 (John Robert Anderson, Philip M. Groves, Gary E. Schwartz)". Am Psychol. 34 (1): 69–79. PMID 396832.

[Petty-1984-5] Petty, TL.; Scoggin, CH.; Rollins, DR.; Repsher, LH. (Sep 1984). "Bitolterol compared to isoproterenol in advanced chronic obstructive pulmonary disease". Chest. 86 (3): 404–8. doi:10.1378/chest.86.3.404. PMID 6380974.

[pmid6995040-6] Kass, I.; Mingo, TS. (Aug 1980). "Bitolterol mesylate (WIN 32784) aerosol. A new long-acting bronchodilator with reduced chronotropic effects". Chest. 78 (2): 283–7. doi:10.1378/chest.78.2.283. PMID 6995040.

[pmid6693665-7] Kemp, JP.; Chervinsky, P.; Orgel, HA.; Meltzer, EO.; Noyes, JH.; Mingo, TS. (Jan 1984). "Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoring". J Allergy Clin Immunol. 73 (1 Pt 1): 32–43. doi:10.1016/0091-6749(84)90481-0. PMID 6693665.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

v t e Adrenergic agonists
α	Template:Navbox subgroup
β	Template:Navbox subgroup
α and β	Epinephrine - Norepinephrine - Cirazoline - Etilefrine
Indirect/ mixed	Amphetamine - Tyramine - Ephedrine - Pseudoephedrine
see also acetylcholinesterase inhibitor

Bitolterol

Overview

References

Navigation menu